DrugInformer Search

Erythema Annulare : Etanercept Vs. Tacrolimus


Erythema annulare centrifugum (also known as "Deep gyrate erythema," "Erythema perstans," "Palpable migrating erythema", and "Superficial gyrate erythema") is a descriptive term for a skin lesion. The lesions form consists of redness (erythema) in a ring form (annulare) that spreads from the center (centrifugum). EAC was first described by Darrier in 1916. Many different terms have been used to classify these types of lesions and it is still controversial on what exactly defines EAC. Some of the types include (deep and superficial) annular erythema, erythema perstans, erythema gyratum perstans, erythema gyratum repens, darier erythema (Deep gyrate erythema & Deep gyrate erythema) and erythema figuratum perstans.

Read more on Wikipedia

Compare Drugs

Please add a drug to the list to compare them side by side.
Add a new Drug

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.